Cerebrospinal fluid and immunological parameters for differentiation of chronic inflammatory central nervous system disease;Differenzialdiagnose chronisch-entzündlicher erkrankungen des zentralnervensystems: Liquordiagnostik und immunologische parameter

Nervenarzt

Volumn 75, Issue 10, 2004, Pages 945-952

  Reske, D ^a   Petereit, H F ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Cerebrospinal fluid; Multiple sclerosis; Neuro Beh et; Neurolupus; Neurosarcoidosis; Sj gren's syndrome

Indexed keywords

BEHCET DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFLAMMATION; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOLOGICAL PARAMETERS; LUPUS ERYTHEMATOSUS; MULTIPLE SCLEROSIS; REVIEW; SARCOIDOSIS; SJOEGREN SYNDROME; SYSTEMIC DISEASE;

BEHCET SYNDROME; CENTRAL NERVOUS SYSTEM DISEASES; CHRONIC DISEASE; GUIDELINES; HUMANS; INFLAMMATION; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; PHYSICIAN'S PRACTICE PATTERNS; SARCOIDOSIS; SJOGREN'S SYNDROME; SYNDROME;

EID: 7944224489     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-004-1699-2     Document Type: Review

References (65)

1. Ainiala H, Loukkola J, Peltola J et al. (2001) The prevalence of neuropsychiatrie syndromes in systemic lupus erythematosus. Neurology 57:496-500
2. Alexander EL (1993) Neurologic disease in Sjogren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 19:869-908
3. Alexander EL, Alexander GE (1983) Aseptic meningoencephalitis in primary Sjogren's syndrome. Neurology 33:593-598.
4. Alexander EL, Malinow K, Lejewski JE et al. (1986) Primary Sjogren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 104:323-330
5. Andersson M, Alvarez-Cermeno J, Bernardl G et al. (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57:897-902
6. Berlit P (2000) Neurologische Manifestationen von Kollagenosen und Vaskulitiden. Akt Neurol 27:405-411
7. Berlit P, Steinbrecher A (2002) Zerebrale Vaskulitis. Fortschr Neurol Psychiatr 70:663-677
8. Bitsch A (2001) Klinische Symptomatik und natürlicher Verlauf der Multiplen Sklerose. In: Zettl UK, Mix E (eds) Multiple Sklerose. Springer, Berlin Heidelberg New York, pp 67-76
9. Borucki SJ, Nguyen BV, Ladoulis CT et al. (1989) Cerebrospinal fluid immunoglobulin abnormalities in neurosarcoidosis. Arch Neurol 46:270-273
10. Brey RL, Escalante A (1998) Neurological manifestations of antiphospholipid antibody syndrome. Lupus 7(Suppl 2):S67-S74
11. Brook I, Controni G, Kassan SS et al. (1979) Lactic acid levels in cerebrospinal fluid from patients with systemic lupus erythematosus. J Rheumatol 6:691-693
12. Brooks ML, Wang AM, Black PM et al. (1989) Subdural mass lesion secondary to sarcoid granuloma MR and CT findings and differential diagnosis. Comput Med Imaging Graph 13:199-205
13. Cariski AT (1981) Isolated CNS sarcoidosis. JAMA 245:62-63
14. Chen RC, McLeod JG (1989) Neurological complications of sarcoidosis. Clin Exp Neurol 26:99-112
15. Delaney P (1977) Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 87:336-345
16. Ernerudh J, Olsson T, Lindstrom F et al. (1983) Cerebrospinal fluid immunoglobulin abnormalities in systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 48:807-813
17. Feinglass EJ, Arnett FC, Dorsch CA et al. (1976) Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine 55:323-339
18. Gibson T, Myers AR (1975) Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis 35:398-406
19. Grand S, Hoffmann D, Bost F et al. (1996) Case report: pseudotumoral brain lesion as the presenting feature of sarcoidosis. Br J Radiol 69:272-275
20. Grigor R, Edmonds J, Lewkonia R et al. (1978) Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis 37:121-128
21. Gullapalli D, Phillips LH 2nd (2002) Neurologic manifestations of sarcoidosis. Neurol Clin 20:59-83
22. Hanly JG, Cassell K, Fisk JD (1997) Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study. Arthritis Rheum 40:1542-1543
23. Hietaharju A, Yli-Kerttula U, Hakkinen V et al. (1990) Nervous system manifestations in Sjogren's syndrome. Acta Neurol Scand 81:144-152
24. Hietaharju A, Jantti V, Korpela M et al. (1993) Nervous system involvement in systemic lupus erythematosus, Sjogren syndrome and scleroderma. Acta Neurol Scand 88:299-308
25. Hirohata S, Hirose S, Miyamoto T (1985) Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity. Arch Intern Med 145:1843-1846
26. International Study Group for Behcet's Disease (1990) Criteria for diagnosis of Behcet's disease. Lancet 335:1078-1080
27. Jennekens FGI, Kater L (1999) The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology 41:605-618
28. Larner AJ, Ball JA, Howard RS (1999) Sarcoid tumour: continuing diagnostic problems in the MRI era. J Neurol Neurosurg Psychiatry 66:510-512
29. Lee KH, Hashimoto SA, Hooge JP et al. (1991) Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 41:657-660
30. Losy J, Mehta PD, Wisniewski HM (1990) Identification of IgG subclasses' oligoclonal bands in multiple sclerosis CSF. Acta Neurol Scand 82:4-8
31. Lowenthal A, Karcher D (1994) Cerebrospinal fluid in multiple sclerosis. Clin Neurosci 2:211-214
32. Mafee MF, Dorodi S, Pai E (1999) Sarcoidosis of the eye, orbit and central nervous system. Role of MR imaging. Radiol Clin North Am 37:73-87
33. Malinow KL, Molina R, Gordon B et al. (1985) Neuropsychiatric dysfunction in primary Sjogren's syndrome. Ann Intern Med 103:344-350
34. Mayer SA, Yim GK, Onesti ST et al. (1993) Biopsy-proven isolated sarcoid meningitis. Case report. J Neurosurg 78:994-996
35. McDonald WI, Compston A, Edan G et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
36. McLean BN, Miller D, Thompson EJ (1995) Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet's disease involving the nervous system. J Neurol Neurosurg Psychiatry 58:548-554
37. Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224-1234
38. Niemela RK, Hakala M (1999) Primary Sjogren's syndrome with severe central nervous system disease. Semin Arthritis Rheum 29:4-13
39. Oksanen V (1986) Neurosarcoidosis: clinical presentations and course in 50 patients. Acta Neurol Scand 73:283-290
40. Poser CM, Raun NE, Poser W (1982) Age at onset, initial symptomatology and the course of multiple sclerosis. Acta Neurol Scand 66:355-362
41. Reiber H, Lange P (1991) Quantification of virus-specific antibodies in Cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 37:1153-1160
42. Reiber H, Ungefehr S, Jacobi C (1998) The intrathecal and oligoclonal immune response in multiple sclerosis. Mult Scler 4:111-117
43. Ricker W, Clark M (1949) Sarcoidosis: a clinical pathologic review of 300 cases. Am J Clin Pathol 1119:725-49
44. Rolak LA, Beck RW, Paty DW et al. (1996) Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial. Neurology 46:368-372
45. Rudick RA, Cookfair DL, Simonian NA et al (1999) Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNβ-1a) for relapsing multiple sclerosis. The Multiple Sclerosis collaborative research group. J Neuroimmunol 93:8-14
46. Scott TF (1988) A new cause of cerebrospinal fluid eosinophilia: neurosarcoidosis. Am J Med 84:973-974
47. Scott TF, Seay AR, Goust JM (1989) Pattern and concentration of IgG in Cerebrospinal fluid in neurosarcoidosis. Neurology 39:1637-1639
48. Serdaroglu P, Yazici H, Ozdemir C et al. (1989) Neurologic involvement in Behcet's syndrome. A prospective study. Arch Neurol 46:265-269
49. Sharief MK, Keir G, Thompson EJ (1990) Intrathecal synthesis of IgM in neurological diseases: a comparison between detection of oligoclonal bands and quantitative estimation. J Neurol Sci 96:131-142
50. Sharief MK, Hentges R, Thomas E (1991) Significance of CSF immunoglobulins in monitoring neurologic disease activity in Behcet's disease. Neurology 41:1398-1401
51. Sharma OP (1997) Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest 112:220-228
52. Sindic G, Cambiaso CL, Depre A et al. (1982) The concentration of IgM in the cerebrospinal fluid of neurological patients. J Neurol Sci 55:339-350
53. Siva A (2001) Vasculitis of the nervous system. J Neurol 248:451-468
54. Soderstrom M, Ya-Ping J, Hillert J et al. (1998) Optic neuritis: prognoses for multiple sclerosis from MRI, CSF, and HLA findings. Neurology 50:708-714
55. Sommer N, Weller M, Petersen D et al. (1991) Neurasarcoidosis without systemic sarcoidosis. Eur Arch Psychiatry Clin Neurosci 240:334-338
56. Stern BJ, Krumholz A, Johns C et al. (1985) Sarcoidosis and its neurological manifestations. Arch Neurol 42:909-917
57. Stern BJ, Griffin DE, Luke RA et al. (1987) Neurosarcoidosis: cerebrospinal fluid lymphocyte subpopulations. Neurology 37:878-881
58. Thompson AJ, Montalban X, Barkhof F et al. (2000) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831-835
59. Tourtellotte WW (1985) The cerebrospinal fluid in multiple sclerosis. In: Bruyn G (ed) Handbook of clinical neurology, vol 3(47). Elsevier, Amsterdam, pp 79-130
60. Tourtellotte WW, Murthy K, Brandes D et al. (1976) Schemes to eradicate the multiple sclerosis central nervous system immune reaction. Neurology 26:59-61
61. Vandvik B, Natvig JB, Wiger D (1976) IgGI subclass restriction of oligoclonal IgG from cerebrospinal fluids and brain extracts in patients with multiple sclerosis and subacute encephalitides. Scand J Immunol 5:427-436
62. Vartdal F, Vandvik B (1983) Multiple sclerosis: subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies. Clin Exp Immunol 54:641-647
63. Vrethem M, Emerudh J, Lindstrom F et al. (1990) Immunoglobulins within the central nervous system in primary Sjogren's syndrome. J Neurol Sci 100:186-192
64. Winfield JB, Shaw M, Silverman LM et al. (1983) Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med 74:837-844
65. Zajicek JP, Scolding NJ, Foster O et al. (1999) Central nervous system sarcoidosis-diagnosis and management. QJM 92:103-17